{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Capparis spinosa L", "MTT assay", "apoptosis", "cell cycle", "clonogenicity", "cytotoxicity"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38819027", "DateCompleted": {"Year": "2024", "Month": "05", "Day": "31"}, "DateRevised": {"Year": "2024", "Month": "06", "Day": "03"}, "Article": {"Language": ["eng"], "ELocationID": ["15347354241256649", "10.1177/15347354241256649"], "ArticleDate": [], "Journal": {"ISSN": "1552-695X", "JournalIssue": {"Volume": "23", "PubDate": {"Year": "2024", "Season": "Jan-Dec"}}, "Title": "Integrative cancer therapies", "ISOAbbreviation": "Integr Cancer Ther"}, "ArticleTitle": "In-vitro Cytotoxicity Investigations for Phytoconstituents of Saudi Medicinal Plants With Putative Ocular Effects.", "Pagination": {"StartPage": "15347354241256649", "MedlinePgn": "15347354241256649"}, "Abstract": {"AbstractText": ["Metastatic secondary ocular tumors spread from systemic malignancies, including breast cancer. This study aimed to evaluate the cytotoxicity of extracts from 5 medicinal plants native to Saudi Arabia.", "For preliminary activity screening, cytotoxicity using the MTT assay and selectivity index determinations were made for medicinal plant extracts against various cancer cell-lines. The most promising extract was subjected to GC-MS analysis to determine the phytochemical composition. Clonogenic assays were performed using the most promising extract to confirm the initial results. Finally, western blot analysis was used to determine the modulation in expression of survivin and P27 suppressor genes in the human breast adenocarcinoma (MCF7) cell-line to understand the potential mechanistic properties of the active plant extract.", "The 5 plant extracts showed various cytotoxic activity levels using IC<sub>50</sub>. The most active extract was found to be the leaves of <i>Capparis spinosa</i> L. (<b>BEP-07</b> extract) against the MCF7 breast cancer cell-line (IC<sub>50</sub>\u2009=\u20093.61\u2009\u00b1\u20090.99\u2009\u03bcg/ml) and selectivity index of 1.17 compared to the normal human fetal lung fibroblast (MRC5) cells. <b>BEP-07</b> extract showed a dose dependent clonogenic effect against the MCF7 colonies which was comparable with the effect of doxorubicin. <b>BEP-07</b> extract caused a significant decrease of survivin and increase in P27 expression compared to control GAPDH at its highest dose (14\u2009\u00b5g/ml). The GC-MS chromatogram of <i>Capparis spinosa</i> L. (<b>BEP-07</b> extract) revealed the existence of 145 compounds, belonging to the diverse classes of phytoconstituents. Fatty acids and their derivatives represent 15.4%, whilst octadecanoic acid, 2,3-dihydroxypropyl ester was the principal component (7.9%) detected.", "Leaves of <i>Capparis spinosa</i> L. (<b>BEP-07</b> extract) exhibited a significant cytotoxic effect particularly against breast cancer cells. It exhibited this effect through survivin inhibition and via P27 upregulation. The detected phytoconstituents in the plant extract might be involved in tested cytotoxic activity, while further investigations are required to complete the drug candidate profile."]}, "AuthorList": [{"Identifier": ["0000-0003-4451-3820"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Al Baha University, Al Baha, Saudi Arabia."}], "LastName": "Alghamdi", "ForeName": "Ali Hendi", "Initials": "AH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Al Baha University, Al Baha, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Omdurman Islamic University, Khartoum, Sudan."}], "LastName": "Ahmed", "ForeName": "Aimun A E", "Initials": "AAE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Al Baha University, Al Baha, Saudi Arabia."}], "LastName": "Abdalgadir", "ForeName": "Haidar", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Al Baha University, Al Baha, Saudi Arabia."}], "LastName": "Bashir", "ForeName": "Mahadi", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Jazan University, Jazan, Saudi Arabia."}], "LastName": "Khalid", "ForeName": "Asaad", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Umm Al-Qura University, Makkah, Saudi Arabia."}, {"Identifier": [], "Affiliation": "National Center for Research, Khartoum, Sudan."}], "LastName": "Abdalla", "ForeName": "Ashraf N", "Initials": "AN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Umm Al-Qura University, Makkah, Saudi Arabia."}], "LastName": "Elzubier", "ForeName": "Mohamed E", "Initials": "ME"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Umm Al-Qura University, Makkah, Saudi Arabia."}], "LastName": "Adnan Almaimani", "ForeName": "Riyad", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Umm Al-Qura University, Makkah, Saudi Arabia."}], "LastName": "Refaat", "ForeName": "Bassem", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Al Baha University, Al Baha, Saudi Arabia."}], "LastName": "Alzahrani", "ForeName": "Khalid", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Al Baha University, Al Baha, Saudi Arabia."}], "LastName": "Alghamdi", "ForeName": "Saleh M S", "Initials": "SMS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Fraunhofer Institute for Translational Medicine and Pharmacology, Hamburg, Germany."}, {"Identifier": [], "Affiliation": "Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, Hamburg, Germany."}], "LastName": "Gul", "ForeName": "Sheraz", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Integr Cancer Ther", "NlmUniqueID": "101128834", "ISSNLinking": "1534-7354"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Survivin"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "BIRC5 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Saudi Arabia"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "MCF-7 Cells"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["metabolism"], "DescriptorName": "Survivin"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["methods"], "DescriptorName": "Gas Chromatography-Mass Spectrometry"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Phytochemicals"}], "CoiStatement": "Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Zhang W, Rokohl AC, Guo Y, et al.. Global incidence and prevalence of malignant orbital tumors. Adv Ophthalmol Pr Res. 2024. doi:10.1016/j.aopr.2024.04.002"}, {"Citation": "Margo CE, Mulla ZD. Malignant tumors of the orbit: analysis of the Florida cancer registry. Ophthalmology. 1998;105:185-190.", "ArticleIdList": ["9442797"]}, {"Citation": "Darwich R, Ghazawi FM, Rahme E, et al.. Epidemiology of ophthalmic lymphoma in Canada during 1992-2010. Br J Ophthalmol. 2020;104:1176-1180.", "ArticleIdList": ["31722877"]}, {"Citation": "Koopman JH, van der Heiden-van der Loo M, van Dijk MR, Bijlsma WR. Incidence of primary malignant orbital tumours in the Netherlands. Eye. 2011;25:461-465.", "ArticleIdList": ["PMC3171243", "21336252"]}, {"Citation": "Cheng CY, Hsu W-M. Incidence of eye cancer in Taiwan: an 18-year review. Eye. 2004;18:152-158.", "ArticleIdList": ["14762407"]}, {"Citation": "Khandekar R, Al-Towerki A, Al-Katan H, et al.. Ocular malignant tumors. Review of the tumor registry at a tertiary eye hospital in central Saudi Arabia.\u2009Saudi Med J. 2014;35:377-384.", "ArticleIdList": ["24749135"]}, {"Citation": "Saad Al-Zomia A, Al-Zehefa IA, Alqarni AM, et al.. A retrospective study of ocular cancer in Saudi Arabia: 25-year analysis. Clin Ophthalmol. 2023;17:3103-3111.", "ArticleIdList": ["PMC10591673", "37877115"]}, {"Citation": "Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environ Health Perspect. 2001;109 Suppl 1:69-75.", "ArticleIdList": ["PMC1240543", "11250806"]}, {"Citation": "Newman DJ, Cragg GM, Snader KM. The influence of natural products upon drug discovery. Nat Prod Rep. 2000;17:215-234.", "ArticleIdList": ["10888010"]}, {"Citation": "Saleem H, Khurshid U, Tousif MI, et al.. A comprehensive review on the botany, traditional uses, phytochemistry, pharmacology and toxicity of Anagallis arvensis (L).: a wild edible medicinal food plant. Food Biosci. 2023;52:102328."}, {"Citation": "WFO. Achillea arabica Kotschy. Published on the Internet. Accessed May\u200928, 2024. https://www.worldfloraonline.org/taxon/wfo-0000135534;jsessionid=B2F3E1AAEB7461700D7A5558FCA415CD"}, {"Citation": "Toplan GG, Ta\u015fk\u0131n T, \u0130\u015fcan G, et al.. Comparative studies on essential oil and phenolic content with in vitro antioxidant, anticholinesterase, antimicrobial activities of Achillea biebersteinii Afan. And A. millefolium subsp. millefolium Afan. L. Growing in eastern Turkey. Molecules. 2022;27:1956. doi:10.3390/molecules27061956", "ArticleIdList": ["10.3390/molecules27061956", "PMC8955464", "35335326"]}, {"Citation": "Akkol EK, Koca U, Pesin I, Yilmazer D. Evaluation of the wound healing potential of Achillea biebersteinii afan. (Asteraceae) by In Vivo excision and incision models. Evid Based Complement Alternat Med. 2011;2011:1-7. doi:10.1093/ecam/nep039", "ArticleIdList": ["10.1093/ecam/nep039", "PMC3136533", "19546149"]}, {"Citation": "Al-Said MS, Mothana RA, Al-Yahya MM, et al.. GC-MS analysis: In Vivo hepatoprotective and antioxidant activities of the essential oil ofAchillea biebersteiniiafan. Growing in Saudi Arabia. Evid Based Complement Alternat Med. 2016;2016 :1867048. doi:10.1155/2016/1867048", "ArticleIdList": ["10.1155/2016/1867048", "PMC4880702", "27293452"]}, {"Citation": "Abd-Alla HI, Shalaby NM, Hamed MA, et al.. Phytochemical composition, protective and therapeutic effect on gastric ulcer and \u03b1-amylase inhibitory activity of Achillea biebersteinii Afan. Arch Pharm Res. 2016;39:10-20. doi:10.1007/s12272-014-0544-9", "ArticleIdList": ["10.1007/s12272-014-0544-9", "25567761"]}, {"Citation": "Mohamed AE, Mohamed NS, Hamed AR, Hegazy MF. Anti-inflammatory activity of highly oxygenated terpenoids from Achillea biebersteinii Afan. Z Naturforsch C. 2016;71:429-432. doi:10.1515/znc-2016-0098", "ArticleIdList": ["10.1515/znc-2016-0098", "27771627"]}, {"Citation": "Varasteh-Kojourian M, Abrishamchi P, Matin M, et al.. Antioxidant, cytotoxic and DNA protective properties of Achillea eriophora DC. and Achillea biebersteinii Afan. extracts: a comparative study. Avicenna J Phytomed. 2017;7:157-168.", "ArticleIdList": ["PMC5355821", "28348971"]}, {"Citation": "Jaffal SM, Abbas MA. Antinociceptive action of Achillea biebersteinii methanolic flower extract is mediated by interaction with cholinergic receptor in mouse pain models. Inflammopharmacology. 2019;27:961-968. doi:10.1007/s10787-018-0524-7", "ArticleIdList": ["10.1007/s10787-018-0524-7", "30196468"]}, {"Citation": "Okkay U, Ferah Okkay I, Aydin IC, et al.. Effects of Achillea millefolium on cisplatin induced ocular toxicity: an experimental study. Cutan Ocul Toxicol. 2021;40:214-220. doi:10.1080/15569527.2021.1919137", "ArticleIdList": ["10.1080/15569527.2021.1919137", "34180746"]}, {"Citation": "Daur I. Chemical properties of the medicinal herb Kaff Maryam (Anastatica hierochuntica L.) and its relation to folk medicine use. Afr J Microbiol Res. 2012;6:5048-5051."}, {"Citation": "Eman A, Tailang M, Benyounes S, Gauthaman K. Antimalarial and hepatoprotective effects of entire plants of Anastatica hierochuntica. Int J Res Pharmacol Pharmacother. 2011;1:24-27."}, {"Citation": "Jaradat N. Medical plants utilized in Palestinian folk medicine for treatment of diabetes mellitus and cardiac diseases. J Al-Aqsa Univ. 2005;9:1-28."}, {"Citation": "Kim Sooi L, Lean Keng S. Herbal medicines: Malaysian women\u2019s knowledge and practice. Evid Based Complement Alternat Med. 2013;2013:10. doi:10.1155/2013/438139", "ArticleIdList": ["10.1155/2013/438139", "PMC3777224", "24093047"]}, {"Citation": "Nakashima S, Matsuda H, Oda Y, et al.. Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells. Bioorg Med Chem. 2010;18:2337-2345. doi:10.1016/j.bmc.2010.01.046", "ArticleIdList": ["10.1016/j.bmc.2010.01.046", "20189399"]}, {"Citation": "Zin SRM, Kassim NM, Alshawsh MA, Hashim NE, Mohamed Z. Biological activities of Anastatica hierochuntica L.: a systematic review. Biomed Pharmacother. 2017;91:611-620. doi:10.1016/j.biopha.2017.05.011", "ArticleIdList": ["10.1016/j.biopha.2017.05.011", "28486192"]}, {"Citation": "Almundarij TI, Alharbi YM, Abdel-Rahman HA, Barakat H. Antioxidant activity, phenolic profile, and nephroprotective potential of Anastatica hierochuntica ethanolic and aqueous extracts against CCl4-induced nephrotoxicity in rats. Nutrients. 2021;13:2973. doi:10.3390/nu13092973", "ArticleIdList": ["10.3390/nu13092973", "PMC8468951", "34578850"]}, {"Citation": "Md Zin SR, Kassim NM, Mohamed Z, Fateh AH, Alshawsh MA. Potential toxicity effects of Anastatica hierochuntica aqueous extract on prenatal development of Sprague-Dawley rats. J Ethnopharmacol. 2019;245:112180. doi:10.1016/j.jep.2019.112180", "ArticleIdList": ["10.1016/j.jep.2019.112180", "31445135"]}, {"Citation": "Md Zin SR, Mohamed Z, Alshawsh MA, Wong WF, Kassim NM. Mutagenicity evaluation of Anastatica hierochuntica L aqueous extract in vitro and in vivo. Exp Biol Med. 2018;243:375-385. doi:10.1177/1535370217748574", "ArticleIdList": ["10.1177/1535370217748574", "PMC6022925", "29237294"]}, {"Citation": "Abdel-Mageed WM, Fayed MAA, Al-Saleem MSM, et al.. Novel polycyclic pyrroloquinazoline alkaloids from Anisotes trisulcus and their biological activity. J Asian Nat Prod Res. 2020;22:1159-1167. doi:10.1080/10286020.2019.1694514", "ArticleIdList": ["10.1080/10286020.2019.1694514", "31868014"]}, {"Citation": "El-Shanawany MA, Sayed HM, Ibrahim SRM, Fayed MAA. New nitrogenous compounds from Anisotes trisulcus. Z Naturforsch C. 2014;69:209-218. doi:10.5560/znc.2013-0116", "ArticleIdList": ["10.5560/znc.2013-0116", "25069159"]}, {"Citation": "Fleurentin J, Hoefler C, Lexa A, Mortier F, Pelt JM. Hepatoprotective properties of Crepis rueppellii and Anisotes trisulcus: two traditional medicinal plants of Yemen. J Ethnopharmacol. 1986;16:105-111. doi:10.1016/0378-8741(86)90065-6", "ArticleIdList": ["10.1016/0378-8741(86)90065-6", "3747559"]}, {"Citation": "El-Shanawany MA, Sayed HM, Ibrahim SRM, Fayed MAA. Chemical constituents, anti-inflammatory, and antioxidant activities of Anisotes trisulcus. Bull Fac Pharm Cairo Univ. 2014;52:9-14."}, {"Citation": "Mansour RB, Jilani IBH, Bouaziz M, et al.. Phenolic contents and antioxidant activity of ethanolic extract of Capparis spinosa. Cytotechnology. 2016;68:135-142. doi:10.1007/s10616-014-9764-6", "ArticleIdList": ["10.1007/s10616-014-9764-6", "PMC4698273", "25377263"]}, {"Citation": "Sher H, Alyemeni M. Ethnobotanical and pharmaceutical evaluation of Capparis spinosa L, validity of local folk and Unani system of medicine. J Med Plants Res. 2010;4:1751-1756."}, {"Citation": "Tlili N, Elfalleh W, Saadaoui E, et al.. The caper (Capparis L.): ethnopharmacology, phytochemical and pharmacological properties. Fitoterapia. 2011;82:93-101. doi:10.1016/j.fitote.2010.09.006", "ArticleIdList": ["10.1016/j.fitote.2010.09.006", "20851750"]}, {"Citation": "Jouad H, Haloui M, Rhiouani H, El Hilaly J, Eddouks M. Ethnobotanical survey of medicinal plants used for the treatment of diabetes, cardiac and renal diseases in the North centre region of morocco (Fez-Boulemane). J Ethnopharmacol. 2001;77:175-182.", "ArticleIdList": ["11535361"]}, {"Citation": "Eddouks M, Maghrani M, Lemhadri A, Ouahidi ML, Jouad H. Ethnopharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the south-east region of Morocco (Tafilalet). J Ethnopharmacol. 2002;82:97-103. doi:10.1016/s0378-8741(02)00164-2", "ArticleIdList": ["10.1016/s0378-8741(02)00164-2", "12241983"]}, {"Citation": "Saleem H, Khurshid U, Sarfraz M, et al.. Investigation into the biological properties, secondary metabolites composition, and toxicity of aerial and root parts of Capparis spinosa L.: an important medicinal food plant. Food Chem Toxicol. 2021;155:112404. doi:10.1016/j.fct.2021.112404", "ArticleIdList": ["10.1016/j.fct.2021.112404", "34246708"]}, {"Citation": "Sonmezdag AS, Kelebek H, Selli S. Characterization of aroma-active compounds, phenolics, and antioxidant properties in fresh and fermented capers (Capparis spinosa) by GC-MS-Olfactometry and LC-DAD-ESI-MS/MS. J Food Sci. 2019;84:2449-2457. doi:10.1111/1750-3841.14777", "ArticleIdList": ["10.1111/1750-3841.14777", "31476250"]}, {"Citation": "Moghadamnia Y, Mousavi Kani S, Ghasemi-Kasman M, Kazemi Kani M, Kazemi S. The anti-cancer effects of Capparis spinosa hydroalcoholic extract. Avicenna J Med Biotechnol. 2019;11:43-47.", "ArticleIdList": ["PMC6359694", "30800242"]}, {"Citation": "Al-Anazi KM, Al-Mareed AA, Farah MA, et al.. Protective effect of Capparis spinosa extract against potassium bromate induced oxidative stress and genotoxicity in mice. Evid Based Complement Alternat Med. 2021;2021:15. doi:10.1155/2021/8875238", "ArticleIdList": ["10.1155/2021/8875238", "PMC7837764", "33531925"]}, {"Citation": "Alkhaibari AM, Alanazi AD. Chemical composition and insecticidal, antiplasmodial, and anti-leishmanial activity of Capparis spinosa essential oil and its main constituents. Evid Based Complement Alternat Med. 2022;2022:9. doi:10.1155/2022/6371274", "ArticleIdList": ["10.1155/2022/6371274", "PMC8825289", "35154348"]}, {"Citation": "Lee Y, Kim J, Kim Y, et al.. Screening of inhibitory effect on aldose reductase of Vietnam herbal medicines (II). Korean J Pharmacogn. 2008;39:324-329."}, {"Citation": "Al-Rehaily AJ, Yousaf M, Ahmad MS, et al.. Chemical and biological study of Flueggea virosa native to Saudi Arabia. Chem Nat Compd. 2015;51:187-188."}, {"Citation": "Singh SV, Manhas A, Kumar Y, et al.. Antimalarial activity and safety assessment of Flueggea virosa leaves and its major constituent with special emphasis on their mode of action. Biomed Pharmacother. 2017;89:761-771. doi:10.1016/j.biopha.2017.02.056", "ArticleIdList": ["10.1016/j.biopha.2017.02.056", "28273638"]}, {"Citation": "Xie QJ, Zhang WY, Wu ZL, et al.. Alkaloid constituents from the fruits of Flueggea virosa. Chin J Nat Med. 2020;18:385-392. doi:10.1016/S1875-5364(20)30045-5", "ArticleIdList": ["10.1016/S1875-5364(20)30045-5", "32451096"]}, {"Citation": "Chao CH, Cheng JC, Shen DY, Wu TS. Anti-hepatitis C virus dinorditerpenes from the roots of Flueggea virosa. J Nat Prod. 2014;77:22-28. doi:10.1021/np400528h", "ArticleIdList": ["10.1021/np400528h", "24400834"]}, {"Citation": "Williams BK, Jr, Di Nicola M. Ocular oncology-primary and metastatic malignancies. Med Clin North Am. 2021;105:531-550. doi:10.1016/j.mcna.2021.02.005", "ArticleIdList": ["10.1016/j.mcna.2021.02.005", "33926645"]}, {"Citation": "Houston SK, Lampidis TJ, Murray TG. Models and discovery strategies for new therapies of retinoblastoma. Expert Opin Drug Discov. 2013;8:383-394. doi:10.1517/17460441.2013.772975", "ArticleIdList": ["10.1517/17460441.2013.772975", "23427911"]}, {"Citation": "Maheshwari A, Finger PT. Cancers of the eye. Cancer Metastasis Rev. 2018;37:677-690. doi:10.1007/s10555-018-9762-9", "ArticleIdList": ["10.1007/s10555-018-9762-9", "30203109"]}, {"Citation": "Mahajan A, Crum A, Johnson MH, Materin MA. Ocular neoplastic disease. Semin Ultrasound CT MR. 2011;32:28-37. doi:10.1053/j.sult.2010.12.001", "ArticleIdList": ["10.1053/j.sult.2010.12.001", "21277489"]}, {"Citation": "Scroggs M, Johnston W, Klintworth G. Intraocular tumors. A cytopathologic study. Acta Cytol. 1990;34:401-408.", "ArticleIdList": ["2343699"]}, {"Citation": "Mullaney PB, Karcioglu ZA, al-Mesfer S, Dowaidi M. Retinoblastoma referral patterns in Saudi Arabia. Ophthalmic Epidemiol. 1996;3:35-46. doi:10.3109/09286589609071599", "ArticleIdList": ["10.3109/09286589609071599", "8705872"]}, {"Citation": "Shao YF, Echegaray JJ, Singh N, Singh AD. Variability of bad prognosis in uveal melanoma. Ophthalmol Retina. 2019;3:186-193. doi:10.1016/j.oret.2018.09.007", "ArticleIdList": ["10.1016/j.oret.2018.09.007", "31014770"]}, {"Citation": "Vaidya S, Dalvin LA, Yaghy A, et al.. Conjunctival melanoma: risk factors for recurrent or new tumor in 540 patients at a single ocular oncology center. Eur J Ophthalmol. 2021;31:2675-2685. doi:10.1177/1120672120970393", "ArticleIdList": ["10.1177/1120672120970393", "33176471"]}, {"Citation": "St\u00e5lhammar G, Herrspiegel C. Long-term relative survival in uveal melanoma: a systematic review and meta-analysis. Commun Med. 2022;2:18. doi:10.1038/s43856-022-00082-y", "ArticleIdList": ["10.1038/s43856-022-00082-y", "PMC9053233", "35603296"]}, {"Citation": "Imhof S, Moll A, Schouten-van Meeteren A. [Intraocular retinoblastoma: new therapeutic options]. Ned Tijdschr Geneeskd. 2001;145:2165-2170.", "ArticleIdList": ["11727614"]}, {"Citation": "Meel R, Radhakrishnan V, Bakhshi S. Current therapy and recent advances in the management of retinoblastoma. Indian J Med Paediatr Oncol. 2012;33:80-88. doi:10.4103/0971-5851.99731", "ArticleIdList": ["10.4103/0971-5851.99731", "PMC3439795", "22988349"]}, {"Citation": "Doz F. R\u00e9tinoblastome : aspects r\u00e9cents [Retinoblatoma: a review]. Arch Pediatr. 2006;13:1329-1337. doi:10.1016/j.arcped.2006.06.017", "ArticleIdList": ["10.1016/j.arcped.2006.06.017", "16930963"]}, {"Citation": "Chintagumpala M, Chevez-Barrios P, Paysse EA, Plon SE, Hurwitz R. Retinoblastoma: review of current management. Oncologist. 2007;12:1237-1246. doi:10.1634/theoncologist.12-10-1237", "ArticleIdList": ["10.1634/theoncologist.12-10-1237", "17962617"]}, {"Citation": "Pogrzebielski A, Shields CL, Romanowska-Dixon B, Shields JA. Siatkowczak\u2013aktualne zalecenia dotyczace postepowania i klasyfikacji (Czesc I) [Retinoblastoma update\u2013management and classification (Part I)]. Klin Oczna. 2006;108:253-257.", "ArticleIdList": ["17020007"]}, {"Citation": "Zhang YN, Xia K-R, Li CY, Wei B-L, Zhang B. Review of breast cancer pathologigcal image processing. Biomed Res Int. 2021;2021:1994764-1994767.", "ArticleIdList": ["PMC8478535", "34595234"]}, {"Citation": "Demirci H, Shields CL, Chao A-N, Shields JA. Uveal metastasis from breast cancer in 264 patients. Am J Ophthalmol. 2003;136:264-271.", "ArticleIdList": ["12888048"]}, {"Citation": "Georgalas I, Paraskevopoulos T, Koutsandrea C, et al.. Ophthalmic metastasis of breast cancer and ocular side effects from breast cancer treatment and management: mini review. Biomed Res Int. 2015;2015 :1-8.", "ArticleIdList": ["PMC4442260", "26078956"]}, {"Citation": "Khawaja MR, Minturn JT, Spittler AJ, Chiorean EG. Ocular metastasis of colorectal cancer: an uncommon presentation of a common malignancy. Hematol Stem Cell Ther. 2015;8:176-180.", "ArticleIdList": ["25784129"]}, {"Citation": "Sun JQ, Wu SN, Mou ZL, et al.. Prediction model of ocular metastasis from primary liver cancer: machine learning-based development and interpretation study. Cancer Med. 2023;12:20482-20496.", "ArticleIdList": ["PMC10652349", "37795569"]}, {"Citation": "Cohen VM. Ocular metastases. Eye. 2013;27:137-141.", "ArticleIdList": ["PMC3574252", "23222564"]}, {"Citation": "Duke JA. Duke\u2019s phytochemical and ethnobotanical database. https://www.sidalc.net/search/Record/dat-usda-us-article24660351"}, {"Citation": "Alsanosy R, Alhazmi HA, Sultana S, et al.. Phytochemical screening and cytotoxic properties of ethanolic extract of young and mature khat leaves. J Chem. 2020;2020:9. doi:10.1155/2020/7897435", "ArticleIdList": ["10.1155/2020/7897435"]}, {"Citation": "Abdalla AN, Malki WH, Qattan A, et al.. Chemosensitization of HT29 and HT29-5FU cell lines by a combination of a multi-tyrosine kinase inhibitor and 5FU downregulates ABCC1 and inhibits PIK3CA in light of their importance in Saudi colorectal cancer. Molecules. 2021;26:334. doi:10.3390/molecules26020334", "ArticleIdList": ["10.3390/molecules26020334", "PMC7827067", "33440689"]}, {"Citation": "Abdalla AN, Qattan A, Malki WH, et al.. Significance of targeting VEGFR-2 and cyclin D1 in luminal-a breast cancer. Molecules. 2020;25: 4606. doi:10.3390/molecules25204606", "ArticleIdList": ["10.3390/molecules25204606", "PMC7594023", "33050377"]}, {"Citation": "Abdalla AN, Abdallah ME, Aslam A, et al.. Synergistic anti leukemia effect of a novel hsp90 and a pan cyclin dependent kinase inhibitors. Molecules. 2020;25:2220. doi:10.3390/molecules25092220", "ArticleIdList": ["10.3390/molecules25092220", "PMC7248782", "32397330"]}, {"Citation": "Munshi A, Hobbs M, Meyn RE. Clonogenic cell survival assay. Methods Mol Med. 2005;110:21-28. doi:10.1385/1-59259-869-2:021", "ArticleIdList": ["10.1385/1-59259-869-2:021", "15901923"]}, {"Citation": "Jaiswal PK, Goel A, Mittal RD. Survivin: a molecular biomarker in cancer. Indian J Med Res. 2015;141:389-397. doi:10.4103/0971-5916.159250", "ArticleIdList": ["10.4103/0971-5916.159250", "PMC4510718", "26112839"]}, {"Citation": "Rostami N, Goharrizi LY. Cloning, expression, and purification of the human synthetic survivin protein in Escherichia coli using response surface methodology (RSM). Mol Biotechnol. 2023;65:326-336. doi: 10.1007/s12033-021-00399-4", "ArticleIdList": ["10.1007/s12033-021-00399-4", "34564769"]}, {"Citation": "Barbareschi M. p27 expression, a cyclin dependent kinase inhibitor in breast carcinoma. Adv Clin Path. 1999;3:119-127.", "ArticleIdList": ["10936889"]}, {"Citation": "Gupta A, Kumar BS, Negi AS. Current status on development of steroids as anticancer agents. J Steroid Biochem Mol Biol. 2013;137:242-270.", "ArticleIdList": ["23727548"]}, {"Citation": "Arora S, Kumar G. Phytochemical screening of root, stem and leaves of Cenchrus biflorus Roxb. J Pharmacogn Phytochem. 2018;7:1445-1450."}]}], "History": [{"Year": "2024", "Month": "5", "Day": "31", "Hour": "12", "Minute": "43"}, {"Year": "2024", "Month": "5", "Day": "31", "Hour": "12", "Minute": "42"}, {"Year": "2024", "Month": "5", "Day": "31", "Hour": "7", "Minute": "53"}, {"Year": "2024", "Month": "5", "Day": "31"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38819027", "PMC11143859", "10.1177/15347354241256649"]}}]}